Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center, Post-market Cosmetic Evaluation of Ariessence™ Pure PDGF+ Following Ablative Laser for the Tolerability and Improvement in the Appearance of Aging Skin.

NCT07718347 is registered in ClinicalTrials.gov with Lynch Regenerative Medicine as lead sponsor.

NCT NCT07718347
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07718347 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center, Post-market Cosmetic Evaluation of Ariessence™ Pure PDGF+ Following Ablative Laser for the Tolerability and Improvement in the Appearance of Aging Skin.
Lead sponsor
Lynch Regenerative Medicine
Phase
Not applicable
Overall status
Recruiting
Start date
April 16, 2026
Completion date
February 28, 2027
Enrollment
21 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

aging, aging mid-face, immediate post-treatment care